Pediatric NTRK-rearranged gliomas: A clinicopathological and molecular analysis of six cases

Jing Zhao1, Feng Tian1, Di Ding1

  • 1Department of Pathology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

PubMed
Abstract

Insights

Pediatric gliomas with neurotrophic tyrosine receptor kinase (NTRK) gene fusions show diverse pathological and molecular features. Routine NTRK testing is recommended for all pediatric gliomas to guide targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Pediatric Medicine

Background:

  • Neurotrophic tyrosine receptor kinase (NTRK) gene fusions are oncogenic drivers in a small percentage of gliomas.
  • Targeted therapies for NTRK-rearranged tumors offer improved outcomes, increasing focus on these rare malignancies.

Purpose of the Study:

  • To characterize the pathological and molecular diversity of pediatric NTRK-rearranged gliomas.
  • To inform the development of targeted therapeutic strategies for these tumors.

Main Methods:

  • Analysis of six pediatric gliomas with NTRK fusions using next-generation DNA sequencing and fluorescence in situ hybridization.
  • Histopathological evaluation and DNA methylation profiling.

Main Results:

  • All analyzed tumors were supratentorial, with varying histological grades and NTRK gene involvement (NTRK1, NTRK2, NTRK3).
  • Complex dual and triple gene fusions were identified, alongside additional genetic alterations in some cases.
  • DNA methylation profiling did not reveal distinct methylation classes.

Conclusions:

  • This study expands the known clinicopathological and molecular spectrum of pediatric NTRK-rearranged gliomas.
  • Complex fusion patterns and rare entities were observed.
  • Routine NTRK testing in pediatric gliomas, regardless of grade, is supported to facilitate targeted treatment.

Related Concept Videos

[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement01:21

[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement

The Cope rearrangement is classified as a [3,3] sigmatropic shift in 1,5-dienes, leading to a more stable, isomeric 1,5-diene. The reaction involves a concerted movement of six electrons, four from two π bonds and two from a σ bond, via an energetically favorable chair-like transition state.
3.5K
[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement01:24

[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement

The Claisen rearrangement is a [3,3] sigmatropic rearrangement of allyl vinyl ethers to unsaturated carbonyl compounds. The rearrangement is a concerted pericyclic reaction proceeding via a chair-like transition state.
2.9K
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy03:07

Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy

The kinetic molecular theory qualitatively explains the behaviors described by the various gas laws. The postulates of this theory may be applied in a more quantitative fashion to derive these individual laws.
30.0K
Preparation of Diols and Pinacol Rearrangement01:57

Preparation of Diols and Pinacol Rearrangement

Compounds bearing two hydroxyl groups are known as diols. When the hydroxyl groups are located on adjacent carbon atoms, the diols are called vicinal diols or glycols. Under acidic conditions, vicinal diols undergo a specific reaction called pinacol rearrangement.
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.
4.3K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279